Gilead Sciences (GILD) Non-Current Assets (2009 - 2026)

Gilead Sciences has reported Non-Current Assets for 18 years, with the latest figure at $37.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 4.8% year-over-year to $37.6 billion; the trailing twelve-month figure through Mar 2026 stood at $160.0 billion (changed 0.24% YoY), and the FY2025 full-year result was $40.7 billion, up 2.16% from the prior year.
• Non-Current Assets for Q1 2026 stood at $37.6 billion, down from $40.7 billion in the prior quarter.
• The five-year high for Non-Current Assets was $50.5 billion in Q1 2022, with the low at $37.6 billion in Q1 2026.
• Historically, Non-Current Assets has averaged $44.1 billion across 5 years, with a median of $42.3 billion in 2024.
• Annual changes were most pronounced in 2024 — Non-Current Assets retreated 14.33% — and 2025, when it gained 2.3%.
• Gilead Sciences' Non-Current Assets stood at $48.7 billion in 2022, then declined by 5.52% to $46.0 billion in 2023, then declined by 13.51% to $39.8 billion in 2024, then grew by 2.16% to $40.7 billion in 2025, then slipped by 7.48% to $37.6 billion in 2026.
• The last three Non-Current Assets figures came in at $37.6 billion (Q1 2026), $40.7 billion (Q4 2025), and $40.7 billion (Q3 2025), per Business Quant data.